Nasal delivery as a strategy for the prevention and treatment of COVID-19.

Sonvico, Fabio; Colombo, Gaia; Quarta, Eride; Guareschi, Fabiola; Banella, Sabrina; Buttini, Francesca; Scherließ, Regina

Sonvico, Fabio; Colombo, Gaia; Quarta, Eride; Guareschi, Fabiola; Banella, Sabrina; Buttini, Francesca; Scherließ, Regina.

Afiliación

Sonvico F; Department of Food and Drug, University of Parma, Parma, Italy.
Colombo G; Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Quarta E; Department of Food and Drug, University of Parma, Parma, Italy.
Guareschi F; Department of Food and Drug, University of Parma, Parma, Italy.
Banella S; Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Buttini F; Department of Food and Drug, University of Parma, Parma, Italy.
Scherließ R; Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany.

Expert Opin Drug Deliv ; 20(8): 1115-1130, 2023.

Article en En | MEDLINE | ID: mdl-37755135

Asunto(s)

COVID-19; Mucosa Nasal; Humanos; COVID-19/prevención & control; Administración Intranasal; Sistemas de Liberación de Medicamentos; Antivirales/uso terapéutico

Palabras clave

Antiviral nasal products; SARS-CoV-2 infection; barrier nasal products; mucosal delivery; nasal vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Mucosa Nasal Límite: Humans Idioma: En Revista: Expert Opin Drug Deliv Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google